Narcan Naloxone Hci NDC 51662-1240

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1240Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1240Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1240-1	51662124001	.1 mL in 1 VIAL, SINGLE-DOSE (51662-1240-1)Marketed from Oct 15, 2018
51662-1240-2	51662124002	2 VIAL, SINGLE-DOSE in 1 PACKAGE (51662-1240-2) / .1 mL in 1 VIAL, SINGLE-DOSEMarketed from Oct 15, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Narcan Naloxone Hci
Generic name (nonproprietary): narcan naloxone hci
Active ingredients: Naloxone hydrochloride — 4 mg/.1mL
Dosage form: Spray
Route: Nasal
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 208411
Marketing start: Oct 15, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Opioid Antagonists (Mechanism)
Identifiers: Product ID 51662-1240_07627f49-62b7-7d91-e063-6294a90a796dSPL ID 07627f49-62b7-7d91-e063-6294a90a796dSPL set ID 784a0e98-c2d6-f845-e053-2991aa0ac4b4RxCUI 1725059UNII F850569PQRUPC 0369547353025
Pharmacologic class: Opioid Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Nasal products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N451662124001 followed by a unit qualifier and the quantity

Package 51662-1240-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 10, 2023.

Indications (excerpt from the label)

NARCAN Nasal Spray is indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression. NARCAN Nasal Spray is intended for immediate administration as emergency therapy in settings where opioids may be present. NARCAN Nasal Spray is not a substitute for emergency medical care. Limitations of Use: Restrict prescription of NARCAN Nasal Spray 2 mg to opioid-dependent patients expected to be at risk for severe opioid withdrawal in situations where there is a low risk for accidental or intentional opioid exposure by household contacts.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 208411

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 208411
Product	Strength	Form · route	Labeler	Product NDC
Narcannaloxone hydrochloride	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Emergent Devices Inc.	69547-353
Narcannaloxone hydrochloride nasal	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Emergent Devices Inc.	69547-627
Naloxone Hydrochloridenaloxone hydrochloride nasal	Naloxone hydrochloride 4 mg/.1mL	InhalantNasal	A-S Medication Solutions	50090-5908
Narcannaloxone hydrochloride nasal	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Sportpharm LLC	85766-076
Narcan Naloxone HCL	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	HF Acquisition Co LLC, DBA HealthFirst	51662-1642
Narcannaloxone hydrochloride	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	A-S Medication Solutions	50090-2422
Narcannaloxone hydrochloride	Naloxone hydrochloride 4 mg/.1mL	SprayNasal	Proficient Rx LP	71205-528